[PDF][PDF] The diagnosis and management of non‐alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American …

N Chalasani, Z Younossi, JE Lavine, AM Diehl… - …, 2012 - Wiley Online Library
These recommendations are based on the following:(1) a formal review and analysis of the
recently published world literature on the topic [Medline search up to June 2011];(2) the …

Nonalcoholic fatty liver disease: an emerging threat to obese and diabetic individuals

HC Masuoka, N Chalasani - Annals of the new York Academy …, 2013 - Wiley Online Library
Nonalcoholic fatty liver disease (NAFLD) is the most common liver disease in the Western
world and its incidence is increasing rapidly. NAFLD is a spectrum ranging from simple …

The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the …

N Chalasani, Z Younossi, JE Lavine, AM Diehl… - …, 2012 - gastrojournal.org
Guidelines; 1 (3) guideline policies of the three societies approving this document; and (4)
the experience of the authors and independent reviewers with regards to NAFLD. Intended …

[HTML][HTML] Evidence-based clinical advice for nutrition and dietary weight loss strategies for the management of NAFLD and NASH

TJ Hydes, S Ravi, R Loomba… - Clinical and Molecular …, 2020 - ncbi.nlm.nih.gov
Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease
worldwide and affects approximately one third of adults in the United States. The disease is …

Association of adipose tissue and liver fibrosis with tissue stiffness in morbid obesity: links with diabetes and BMI loss after gastric bypass

M Abdennour, S Reggio, G Le Naour… - The Journal of …, 2014 - academic.oup.com
Context: Liver and white adipose tissue (WAT) develop inflammation and fibrosis. Objective:
The aim of the study was to evaluate the bioclinical relevance of WAT fibrosis in morbid …

Liver-specific GH receptor gene-disrupted (LiGHRKO) mice have decreased endocrine IGF-I, increased local IGF-I, and altered body size, body composition, and …

EO List, DE Berryman, K Funk, A Jara, B Kelder… - …, 2014 - academic.oup.com
GH is an important regulator of body growth and composition as well as numerous other
metabolic processes. In particular, liver plays a key role in the GH/IGF-I axis, because the …

Genetics of murine type 2 diabetes and comorbidities

IM Lone, FA Iraqi - Mammalian Genome, 2022 - Springer
Abstract Type 2 diabetes (T2D) is a polygenic and multifactorial complex disease, defined as
chronic metabolic disorder. It's a major global health concern with an estimated 463 million …

[HTML][HTML] Insulin sensitizers for the treatment of non-alcoholic fatty liver disease

ZA Ozturk, A Kadayifci - World journal of hepatology, 2014 - ncbi.nlm.nih.gov
Non-alcoholic fatty liver disease (NAFLD) is the leading cause of liver disease in the
Western world and is closely associated with metabolic syndrome, which includes …

[PDF][PDF] Nonalcoholic Fatty Liver Disease: Status Quo.

I Sporea, A Popescu, D Dumitraşcu, C Brisc… - … of Gastrointestinal & …, 2018 - roald.ro
Nonalcoholic liver disease (NAFLD) is a hot topic for gastroenterologists and hepatologists
and clinical practitioners must be kept abreast with the rapid progress of knowledge in this …

Hepatic FGF21 mediates sex differences in high-fat high-fructose diet-induced fatty liver

N Chukijrungroat, T Khamphaya… - American Journal …, 2017 - journals.physiology.org
The role of gender in the progression of fatty liver due to chronic high-fat high-fructose diet
(HFFD) has not been studied. The present investigation assessed whether HFFD induced …